RxDoctor Payments DataLook up a doctor →

Javier Morales, MD

Infectious Disease · San Juan, PRNPI 1346231040

Payments from drug & device makers

$5,879,555in general payments, 2019–2025

Across 1,117 payments — averaging $5263.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.8M
  • Modernatx, Inc.$962K
  • Viiv Healthcare Company$837K
  • Sanofi Pasteur Inc.$801K
  • AbbVie$539K
  • Gilead$415K
  • plus $477K from 11 others
$6,145in research payments, 2019–2025

Across 20 payments — averaging $307.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$4K
  • Gilead$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck283$1,848,268
Modernatx, Inc.132$961,739
Viiv Healthcare Company164$837,130
Sanofi Pasteur Inc.119$801,053
AbbVie(2 entities)177$539,084
Gilead93$415,427
Janssen Research & Development, LLC37$195,604
GSK60$120,250
Pfizer28$83,214
Sanofi US Services Inc.12$68,439
Organon6$9,176
Boston Scientific1$42
Janssen Products, LP1$30
Boehringer Ingelheim1$27
Johnson & Johnson1$26
AstraZeneca1$24
Insmed, Inc.1$22

How this compares

$5,879,555 in reported general payments places this provider in the 95th percentile of 127 infectious disease providers in Puerto Rico.

See all infectious disease providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$5,213
Medicare patients
29
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →